24 results
8-K
EX-99.1
INVA
Innoviva Inc
13 May 24
Corporate Presentation May 2024
9:27am
device Historical resilience in a competitive, volatile environment supported by positive demographic trends Implied royalties ($M) Royalty assets 1
8-K
EX-99.1
INVA
Innoviva Inc
24 May 23
Corporate Presentation May 2023
5:18pm
globally Historical resilience in a competitive, volatile environment supported by positive demographic trends Implied royalties ($M) 69 116 114 71 92
8-K
EX-99.1
INVA
Innoviva Inc
14 Sep 22
Regulation FD Disclosure
5:22pm
deviceFastest growing major ICS / LABA therapy globallyHistorical resilience in a competitive, volatile environment supported by positive demographic
SC TO-C
EX-99.2
0a1ym 4t9
23 May 22
Information about tender offer
8:54pm
8-K
EX-99.1
2codq kaok
7 Apr 22
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
59nb99q
13 Dec 21
Corporate Presentation December 2021
4:39pm
8-K
EX-99.1
ijjyoba
24 Oct 12
An analysis of the dose response of umeclidinium (GSK573719) administered once or twice daily in patients with COPD
12:00am
8-K
EX-99.16
8s2qr8
4 Sep 12
Other Events
12:00am
8-K
EX-99.15
b0sbjtm
4 Sep 12
Other Events
12:00am
8-K
EX-99.12
e8wm7ghqnb
4 Sep 12
Other Events
12:00am
8-K
EX-99.3
vx87alij57hrhd5
22 May 12
Other Events
12:00am
8-K
EX-99.2
gbmfyibdksoeq
22 May 12
Other Events
12:00am
8-K
EX-99.1
ezjjky0f4ws
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am
8-K
EX-99.1
zqs tv8evr440tofd3
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.4
v24nwx02n50559q
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.3
co5ufzo2otts5p
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.1
q6y yb1hu
18 May 10
Other Events
12:00am